IN2013MU03773A - - Google Patents

Download PDF

Info

Publication number
IN2013MU03773A
IN2013MU03773A IN3773MU2013A IN2013MU03773A IN 2013MU03773 A IN2013MU03773 A IN 2013MU03773A IN 3773MU2013 A IN3773MU2013 A IN 3773MU2013A IN 2013MU03773 A IN2013MU03773 A IN 2013MU03773A
Authority
IN
India
Prior art keywords
hyaluronic acid
crosslinked hyaluronic
preparation
composition
same
Prior art date
Application number
Other languages
English (en)
Inventor
Joon Ho Lee
Chung Lee
Han Seung Lee
Original Assignee
Lg Life Sciences Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lg Life Sciences Ltd filed Critical Lg Life Sciences Ltd
Publication of IN2013MU03773A publication Critical patent/IN2013MU03773A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
IN3773MU2013 2013-03-27 2013-12-02 IN2013MU03773A (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020130032956A KR101869988B1 (ko) 2013-03-27 2013-03-27 점탄성 히알루론산 가교물 제조용 조성물, 및 이를 이용하여 얻은 히알루론산 가교물

Publications (1)

Publication Number Publication Date
IN2013MU03773A true IN2013MU03773A (pl) 2015-08-07

Family

ID=51594442

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3773MU2013 IN2013MU03773A (pl) 2013-03-27 2013-12-02

Country Status (10)

Country Link
KR (1) KR101869988B1 (pl)
CN (2) CN110078978A (pl)
AR (1) AR093689A1 (pl)
BR (1) BR102013030668B1 (pl)
IN (1) IN2013MU03773A (pl)
MX (1) MX366526B (pl)
MY (1) MY169325A (pl)
RU (1) RU2568998C2 (pl)
TR (1) TR201313318A2 (pl)
TW (1) TWI522134B (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160268291A1 (en) * 2015-03-13 2016-09-15 Kabushiki Kaisha Toshiba Semiconductor device and manufacturing method of semiconductor device
KR101720426B1 (ko) 2015-09-01 2017-04-14 (주)시지바이오 히알루론산 조성물 및 그의 제조방법
CN112423798B (zh) * 2018-07-06 2022-07-19 株式会社Lg化学 具有高粘弹性和高内聚性的透明质酸填充剂
ES2974233T3 (es) * 2018-07-10 2024-06-26 Lg Chemical Ltd Relleno de ácido hialurónico con alta capacidad de elevación y baja fuerza de inyección
CA3121313C (en) 2018-12-21 2023-07-18 Lg Chem, Ltd. Filler comprising hyaluronic acid hydrogel having excellent filling properties
KR102395184B1 (ko) * 2020-03-10 2022-05-10 (주)메디톡스 단일상도 아니고 이성상도 아닌 히알루론산 가교체, 및 이의 용도

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5827937A (en) * 1995-07-17 1998-10-27 Q Med Ab Polysaccharide gel composition
CA2237192C (en) * 1995-11-15 2006-06-20 Seikagaku Corporation Photocured crosslinked-hyaluronic acid gel and method of preparation thereof
FR2811996B1 (fr) * 2000-07-19 2003-08-08 Corneal Ind Reticulation de polysaccharide(s), preparation d'hydrogel(s) ; polysaccharide(s) et hydrogel(s) obtenus,leurs utilisations
SE0401182D0 (sv) * 2004-05-05 2004-05-05 Q Med Ab Novel use of a viscoelastic composition
EP1818344A4 (en) * 2004-11-15 2012-04-18 Shiseido Co Ltd METHOD FOR SYNTHESIZING RETICULATED HYALURONIC ACID GEL
KR100852944B1 (ko) * 2007-02-15 2008-08-19 (주)아모레퍼시픽 화학적으로 가교된 히알루론산 하이드로겔 나노입자의제조방법
CN101244290A (zh) * 2007-11-30 2008-08-20 顾其胜 一种用于组织填充的交联透明质酸微粒凝胶的制备方法
CN101538377A (zh) * 2008-03-20 2009-09-23 上海昊海生物科技有限公司 一种交联透明质酸凝胶及其制备方法
CN101759881A (zh) * 2008-10-08 2010-06-30 上海建华精细生物制品有限公司 一种医用交联透明质酸钠凝胶衍生产品及其制备方法
CN101724164B (zh) * 2008-10-31 2011-12-14 科妍生物科技股份有限公司 交联透明质酸的制造方法
CN102188712A (zh) * 2010-03-04 2011-09-21 上海其胜生物制剂有限公司 一种可注射用凝胶微粒的制备方法
CN102120833A (zh) * 2011-01-10 2011-07-13 深圳市资福药业有限公司 一种透明质酸盐凝胶颗粒及其制备方法
CN102952275A (zh) * 2011-08-19 2013-03-06 上海建华精细生物制品有限公司 一种双相技术运用的透明质酸凝胶及其制备方法

Also Published As

Publication number Publication date
KR20140117956A (ko) 2014-10-08
RU2568998C2 (ru) 2015-11-20
BR102013030668A8 (pt) 2018-05-08
BR102013030668B1 (pt) 2020-04-07
RU2013153007A (ru) 2015-06-10
MX366526B (es) 2019-07-11
BR102013030668A2 (pt) 2015-08-04
CN110078978A (zh) 2019-08-02
TR201313318A2 (tr) 2014-10-21
TW201436827A (zh) 2014-10-01
TWI522134B (zh) 2016-02-21
CN104072814A (zh) 2014-10-01
KR101869988B1 (ko) 2018-06-21
MX2013013828A (es) 2014-09-26
MY169325A (en) 2019-03-21
AR093689A1 (es) 2015-06-17

Similar Documents

Publication Publication Date Title
PH12017501956A1 (en) Compositions of obeticholic acid and methods of use
AU2015207757A8 (en) N-azaspirocycloalkane substituted n-heteroaryl compounds and compositions for inhibiting the activity of SHP2
EA201692301A1 (ru) Производные бороновой кислоты и их терапевтическое применение
EA201692526A1 (ru) Замещенные [1,2,4]триазольные соединения
WO2014086982A3 (en) Stable metal compounds, their compositions and methods of their use
EA201590887A1 (ru) Композиция
EA201692525A1 (ru) Замещенные соединения [1,2,4]триазола и имидазола в качестве фунгицидов
IN2013MU03773A (pl)
MX2016005760A (es) Inhibidores de glucogeno sintasa cinasa 3 (gsk-3).
CR20200275A (es) Hidroxiisoxazolinas y derivados de estos
PH12015502118A1 (en) Pyridin-4-yl derivatives
MX2020002123A (es) Sales de ribociclib y formas en estado sólido de las mismas.
MX349265B (es) Composiciones antimicrobianas liquidas de baja formacion de espuma, modificadas reologicamente, y sus metodos de uso.
MX345926B (es) Nuevas composiciones, producción de las mismas y uso de las mismas para la producción de poliamidas coladas.
EA201692289A1 (ru) Замещенные [1,2,4]триазольные и имидазольные соединения в качестве фунгицидов
MX2016008402A (es) Composiciones acuosas solubles de polimeros de acido poli-itaconico seleccionados.
UA113540C2 (xx) Поліморфи n-(2-метоксибензоїл)-4-$(метиламінокарбоніл)аміно]бензолсульфонаміду
IN2014CH00304A (pl)
MX2015012211A (es) Liquidos ionicos y usos de los mismos.
EA201690797A1 (ru) Новые соединения
MX367773B (es) Forma salina sólida de la alfa-6-mpeg6-o-hidroxicodona como agonistas opioides y sus usos.
PH12017501147A1 (en) Total synthesis of trioxacarcin dc-45-a2 and preparation of trioxacarcin analogs
EA201492173A1 (ru) Дронедарон для применения при лейшманиозе, в составах и комбинациях для применения при лейшманиозе
MX2017001900A (es) Composicion nasal con capacidades de formacion de pelicula.
UA84257U (ru) ПРИМЕНЕНИЕ НАТРИЕВОЙ СОЛИ 4-(2-ОКСО-3-МЕТИЛ-2H-[1,2,4]ТРИАЗИНО[2,3-с]-ХИНАЗОЛИН-6-ИЛ)БУТАНОВОЙ КИСЛОТЫ КАК ЦЕРЕБРОПРОТЕКТОРНОГО СРЕДСТВА